Clinical Trials in Los Angeles

Showing 4001-4020 of 16,901 trials

Observation Study in Patients Age 0-5 Years With LAMA2-related Congenital Muscular Dystrophy

NCT06503367

The goal of this observational study is to understand how young children with LAMA2-related dystrophy move and change over time. We will also learn about how this condition impacts other body systems. Participants will undergo: * Neuromuscular assessments * Blood collections * Swallowing and breathing assessments * Questionnaires

LAMA2-MD \(Merosin Deficient Congenital Muscular Dystrophy, MDC1A\)

Nationwide Children's Hospital44 participantsStarted May 2025

Los Angeles, California, United States • Stanford, California, United States • Chicago, Illinois, United States +11 more locations

COMPLETEDPhase 2< 1 mile

COVID19 SARS Vaccinations: Systemic Allergic Reactions to SARS-CoV-2 Vaccinations

NCT04761822

Background: Allergic reactions have been reported to occur after vaccination with both the Pfizer-BioNTech COVID-19 Vaccine and Moderna COVID-19 Vaccine. Allergic reactions range from mild to severe and include life- threatening anaphylactic reactions, although no deaths have been reported with either vaccine. This study is designed with two principal aims: * To estimate the proportions of systemic allergic reactions to the Pfizer-BioNTech COVID-19 Vaccine and the Moderna COVID-19 Vaccine in a High-Allergy/Mast Cell Disorder (HA/MCD) population, and * If the risk in the HA/MCD is demonstrable, to determine whether the proportions are higher in the HA/MCD in comparison to a representative population without severe allergies or mast cell disorders

SARS-CoV InfectionCOVID-19Allergic Reaction+1 more

National Institute of Allergy and Infectious Diseases (NIAID)746 participantsStarted Apr 2021

Tucson, Arizona, United States • Little Rock, Arkansas, United States • Los Angeles, California, United States +26 more locations

Observation Study in Patients Age 0-5 Years With LAMA2-related Congenital Muscular Dystrophy

COVID19 SARS Vaccinations: Systemic Allergic Reactions to SARS-CoV-2 Vaccinations

Find Trials by Condition in Los Angeles

FID-007 in Treating Participants With Advanced Solid Tumors

The MOOD Study - External Combined Occipital and Trigeminal Nerve Stimulation (eCOT-NS) for the Treatment of Major Depressive Disorder (MDD)

Experimental PET Imaging Scans Before Cancer Surgery to Study the Amount of PET Tracer Accumulated in Normal and Cancer Tissues

Double Blind Placebo Controlled Controlled Study of Adjuvant MEDI4736 In Completely Resected NSCLC

Evaluation of the ctDNA LUNAR Test in an Average Patient Screening Episode

PH Sensitive MRI Based Resections of Glioblastoma

Study of SAR447537 (INBRX-101) Compared to Plasma-derived A1PI Therapy in Adults With AATD Emphysema

In Line Aerosol Nebulization With High Flow

A Study to Assess the Safety, Tolerability, and Immunogenicity of RSVpreF in Adults at High Risk of Severe RSV Disease

The Imperative Trial: Treatment of Acute Ischemic Stroke With the Zoom Reperfusion System

A Study to Evaluate the Efficacy and Safety of 2 Doses of EYE103 Compared With Ranibizumab (0.5 mg) in Participants With DME

Safety and Efficacy of MAK683 in Adult Patients With Advanced Malignancies

Phase 2 Study of INV-202 in Patients With Diabetic Kidney Disease

Ph II Study of Cabozantinib With Pembrolizumab in Metastatic Gastric and Gastroesophageal Adenocarcinoma

To Assess the Efficacy and Safety of INCB054707 in Participants With Hidradenitis Suppurativa

A Phase 1/2 Study of INCB001158 in Combination With Chemotherapy in Subjects With Solid Tumors

Expanded Access of Sotorasib

Study of ORIC-944 in Patients With Metastatic Prostate Cancer